文献速递乳腺病理

乳腺病理报告中的决策:临床相关阈值的影响

Decision-making in breast pathology reporting: the effect of clinical relevant thresholds.
PubMed 文献 · Histopathology · 2025-08-05

该研究基于荷兰国家病理登记库2014-2022年数据,回顾性分析原发性浸润性乳腺癌标本,探讨病理医生在临床相关阈值附近的决策行为。结果发现肿瘤大小在1.0和2.0 cm阈值附近存在回避现象,雌激素受体(ER)/孕激素受体(PgR)在10%阈值附近趋向于判定为阳性。

要点

  • 病理医生报告肿瘤大小时会回避1.0和2.0 cm阈值。
  • ER/PgR低表达时倾向于在10%阈值附近判为阳性。
  • 这些决策行为对治疗决策的影响尚需进一步研究。

核心结论

  • 病理医生在决策过程中会考虑临床阈值,肿瘤大小回避1.0和2.0 cm,ER/PgR在阈值附近趋向判为阳性。

研究设计与样本

  • 回顾性、基于人群的分析,使用荷兰国家病理登记库真实世界数据,纳入2014-2022年诊断的原发性浸润性乳腺癌标本。

主要发现

  • 共分析64,099例乳腺癌的肿瘤直径,较大肿瘤(>2 cm)四舍五入至最接近的半厘米或整厘米,较小肿瘤仅四舍五入至半厘米,且回避1.0和2.0 cm阈值。
  • 共分析74,502例乳腺癌的ER/PgR评估,低ER表达时四舍五入至5%的倍数,但在荷兰临床相关阈值10%附近,病理医生使用9%和11%进行半定量,趋向于将病例分类为刚好阳性(10%或11%)。

临床怎么用

  • 病理医生报告乳腺肿瘤大小和ER/PgR状态时需注意临床阈值附近的决策偏倚,确保报告准确性。

局限性

  • 原文未明确说明局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: In breast cancer (BC) pathology reports, small differences around cut-off values can impact staging and consequently, clinical decision-making. Several pathology variables are not very exact, leaving room for interpretation by the pathologist. Therefore, the aim of this study was to investigate pathologists' decision-making around clinically relevant cut-off values. METHODS: We performed a retrospective, population-based analysis of primary invasive BC specimens using real-world data from the Dutch National Pathology Registry. Data collection included tumour diameter and oestrogen receptor (ER)/progesterone receptor (PgR) status from patients diagnosed between 2014 and 2022. RESULTS: Overall, 64,099 BCs were analysed for tumour diameter. For larger tumours (>2 cm), rounding was observed to the nearest half or whole centimetre. For smaller tumours, rounding occurred only to half centimetres, while there was an avoidance of the 1.0 and 2.0 cm thresholds. For ER/PgR assessment, 74,502 BCs were analysed. In cases with low ER expression, rounding was observed at multiples of 5%. However, around the clinically relevant cut-off value of 10% in the Netherlands, pathologists tend to semiquantify the percentage of ER and/or PgR expression by also using 9% and 11%, with a trend to classify a case as just positive (10% or 11%). CONCLUSION: Pathologists take clinical cut-off values into account in their decision-making process. For tumour size, they tend to avoid the 1.0 and 2.0 cm thresholds. For ER/PgR, they tend to categorize the tumour as positive around the threshold. Further research is needed to determine the implication of this for treatment decisions.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Kain ZE, Baez-Navarro X, Linn SC, et al. Decision-making in breast pathology reporting: the effect of clinical relevant thresholds. Histopathology. 2025. PMID: 41219136. doi:10.1111/his.15529

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。